Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Leap Therapeutics, Inc.
Leap Therapeutics, Inc.
Incyte Corporation
Leap Therapeutics, Inc.
Gradalis, Inc.
Elevation Oncology
Labcorp Corporation of America Holdings, Inc
Kineta Inc.
SpeciCare
ImmunoFrontier, Inc.
Precision Therapeutics
Astellas Pharma Inc